I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-43.97%
Change (1 year)
Categories
I-Mab Biopharma (IMAB) - P/B ratio
P/B ratio as of May 2024 : 0.4222
According to I-Mab Biopharma's latest financial reports the company has a price-to-book ratio of 0.4222.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
I-Mab Biopharma - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.4653 | -43.49% |
| 2022-12-31 | 0.8233 | -84.45% |
| 2021-12-31 | 5.29 | 35.11% |
| 2020-12-31 | 3.92 | |
| 2019-12-31 | N/A | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6372 | 50.93% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | 364.00% | 🇺🇸 USA |